Bryan Johnson’s Autoimmune Gastritis and the Missing Metric in Longevity: Biological Fidelity

Bryan Johnson can optimize nutrients, organs, and performance and still face an autoimmune attack. RF Safe explains why longevity must measure bioelectric timing, mitochondrial redox, and biological fidelity, not just chemical age.

Excerpt: The body is not a chemical inventory. It is a bioelectric timing system. Bryan Johnson’s autoimmune gastritis shows how youthful biomarkers can coexist with a control system that has misclassified self as danger. The missing metric in longevity is Fidelity Age.

A Body Can Look 18 and Still Lose the Timing

Bryan Johnson’s autoimmune gastritis reveals why longevity science must measure biological fidelity, not just biological age

Bryan Johnson has spent years building one of the most measured human bodies in history. He tracks sleep, cardiovascular function, hormones, fertility, inflammation, body composition, cognition, micronutrients, environmental contaminants, and hundreds of other variables. He has reported that several of his organs and performance measures resemble those of much younger adults.

Then his team found autoimmune gastritis.

This is not a reason to mock Johnson, and it is not proof that his longevity program failed. It is a far more important scientific signal.

A person can improve the condition of many biological parts while a deeper control system continues to make the wrong decision.

Autoimmune gastritis is not fundamentally an iron problem. Low ferritin is one of its downstream consequences. The upstream problem is that immune cells have classified part of the stomach’s own acid-producing machinery as a target. Autoreactive immune cells attack gastric parietal cells and the H+/K+-ATPase proton pump. Replacing iron can improve the shortage, but it does not automatically correct the self-recognition error that created the shortage. [1][2]

That distinction exposes the largest blind spot in modern longevity science.

We are becoming extremely good at measuring the condition of biological components. We are still poor at measuring whether those components are communicating with the correct timing, phase, gain, threshold, and recovery.

The body is not only a chemical factory. It is an electrically timed, redox-coupled, information-processing system.

You can rebuild the engine and still lose the timing.

The New Engine Problem

Imagine constructing a brand-new high-performance engine.

The cylinders are perfect. The bearings are new. The oil is clean. The fuel mixture is ideal. Every tolerance has been measured and corrected.

Now shift the ignition timing.

You do not need to pour sand into the motor. You do not need to break a piston. Repeated combustion at the wrong point in the cycle can create knock, destructive pressure, excess heat, bearing stress, and eventual failure.

Every individual part can appear healthy while the integrated system damages itself because the timing is wrong.

Human biology is vastly more timing-sensitive than an engine.

Calcium can trigger secretion, contraction, metabolism, repair, differentiation, immune activation, or cell death. Reactive oxygen species can serve as precise signals or become damaging oxidants. Cytokines can defend tissue during infection or drive chronic self-attack. The biological meaning of each signal depends on where it occurs, when it occurs, how long it lasts, what preceded it, and whether the system returns cleanly to baseline.

The molecules can be correct while the chronology is wrong.

Chemistry supplies the components. Timing helps determine the instruction.

State Age, Performance Age, and Fidelity Age

Longevity programs typically emphasize two kinds of measurement.

State Age asks how young or damaged the components appear. It includes blood chemistry, epigenetic marks, inflammation, lipids, hormones, organ structure, and molecular damage.

Performance Age asks what output the system can produce. It includes strength, endurance, glucose control, fertility, cognition, cardiovascular capacity, and recovery from exercise.

Both matter. Neither fully measures the quality of the controller.

Fidelity Age asks a different question:

How accurately does the body interpret a perturbation, select the correct response, coordinate that response across biological scales, and return to a stable state without creating collateral damage?

Fidelity Age includes:

  • Signal discrimination
  • Timing accuracy
  • Phase stability
  • Appropriate gain
  • Recovery speed
  • Resistance to off-target activation
  • Ability to preserve self versus non-self
  • Ability to maintain a stable tissue identity under stress

A person can improve State Age and Performance Age while an older immune-control error remains embedded in the system.

That is exactly why Johnson’s diagnosis is so important. It shows that youthful parts do not guarantee youthful control fidelity.

Autoimmunity Is a Failure of Biological Classification

The immune system is often described as a collection of cells that recognize molecular targets. That description is incomplete.

Immune cells do not make decisions from antigen identity alone. They integrate antigen strength, co-stimulation, inhibitory signals, membrane voltage, calcium timing, mitochondrial state, redox balance, cytokines, tissue context, prior activation, and metabolic reserve.

T cells have been shown experimentally to filter oscillatory inputs according to timing. The same general amount of stimulation can produce different downstream responses when its temporal pattern changes. In other words, immune cells do not merely count signals. They decode rhythm. [3]

That makes immune tolerance a dynamic control problem.

A high-fidelity immune system must continuously solve questions such as:

  • Is this signal self or foreign?
  • Is it harmless or dangerous?
  • Is the threat local or systemic?
  • Should the response be temporary or remembered?
  • Has the danger ended?
  • Should the system attack, tolerate, repair, or stand down?

Those decisions depend on timing hardware.

In T cells, Kv1.3 potassium channels help regulate membrane voltage and preserve the electrical driving force needed for calcium entry. The STIM1-ORAI1 system then provides a major route for sustained calcium signaling. Mitochondria help shape the duration of that signal, provide ATP, control redox state, and influence whether activation remains proportionate or becomes persistent. Autoreactive effector-memory T cells can become highly dependent on Kv1.3, and selective Kv1.3 blockade has been shown to suppress their calcium signaling, cytokine production, and proliferation in experimental autoimmune systems. [4][5]

The immune decision is therefore produced by a timed sequence:

Membrane state. Calcium pattern. Mitochondrial execution. Redox feedback. Nuclear interpretation. Recovery or memory.

When that sequence loses precision, the problem is not limited to one molecule. The entire classification process can drift.

Low-Fidelity Biology Is the Meta-Disease State

RF Safe defines low-fidelity biology as a decline in the reliability with which biological inputs are converted into appropriate state changes, metabolic execution, feedback, and persistent updates.

In high-fidelity biology:

  • The correct input reaches the correct receiver.
  • The signal has the correct amplitude and timing.
  • Mitochondria supply the required energy without excessive redox cost.
  • The response is proportional to the task.
  • The system shuts down when the task is complete.
  • Repair restores the original operating range.

In low-fidelity biology:

  • Signals arrive with altered gain or phase.
  • Calcium and membrane dynamics become less precise.
  • Mitochondrial redox cost rises.
  • Recovery becomes incomplete.
  • Stress pathways remain active after the original need has passed.
  • Compensation changes the future response of the system.
  • The body begins learning from a distorted environment.

This is why low-fidelity biology does not map neatly to one disease.

It is upstream of disease labels.

In one tissue, declining fidelity can weaken immune tolerance. In another, it can impair insulin timing. In another, it can disrupt developmental patterning. In another, it can alter apoptosis, repair, or growth control.

Cancer, autoimmunity, metabolic dysfunction, neurodevelopmental injury, and degeneration are not the same disease. They can still become more accessible when the control architecture that normally preserves timing, identity, repair, and tissue-level goals loses fidelity.

That is the meta-disease state.

It is not a claim that one exposure produces every disease. It is the recognition that many diseases become easier to enter when the biological system loses the precision required to remain inside its healthy attractors.

Why Radiofrequency Exposure Belongs in the Fidelity Equation

The electromagnetic environment is routinely excluded from longevity medicine because conventional exposure limits ask a narrow question: does the exposure heat tissue enough to cause acute damage?

That is not the same as asking whether a time-structured field can alter biological timing, redox balance, calcium dynamics, membrane behavior, or gene regulation without producing dangerous heating.

The evidence that radiofrequency exposure can be biologically active below overt thermal injury is no longer a fringe proposition.

First, a large experimental literature reports oxidative and redox effects after low-intensity RF exposure. A widely cited review evaluated 100 experimental studies and reported oxidative effects in 93 of them. A later WHO-commissioned systematic review described the literature as heterogeneous and assigned low certainty to many pooled conclusions. That heterogeneity does not make the repeated biological observations disappear. It shows why waveform, tissue, timing, dose, developmental state, and receiver biology cannot be collapsed into one average number. [6][7]

Second, a 2026 Cell study used a CRISPR screen to identify CYB5B, a redox protein on the outer mitochondrial membrane, as essential to a controlled electromagnetic-field-inducible gene switch. The field produced CYB5B-dependent rhythmic calcium oscillations that drove gene expression. This was a defined experimental EMF system, but its mechanistic lesson is fundamental: a field can be transduced through mitochondrial redox machinery into calcium timing and nuclear output. [8]

Third, a randomized, double-blind human study reported that a 3.6 GHz RF exposure shifted sleep-spindle frequency in carriers of a particular noncoding CACNA1C variant, while matched carriers of another genotype did not show the same response. The study was small and acute, but it demonstrated a critical principle: the same physical exposure can be transformed differently by different biological receivers. [9]

Fourth, the FDA-authorized TheraBionic P1 system deliberately uses specific amplitude-modulated RF frequencies to treat advanced liver cancer. The FDA describes the device as an RF electromagnetic-field generator that may stop cancer cells from dividing, and the device is contraindicated for patients receiving calcium-channel blockers. This is not evidence that therapeutic RF and ambient Wi-Fi have the same effect. It is decisive evidence against the claim that low-level RF can only matter by heating tissue. Frequency, modulation, receptor state, and biological context matter. [10]

These findings converge on the same systems principle:

Biological outcome is not determined by field strength alone. It emerges from the interaction between the waveform and the receiver.

The receiver includes genotype, channel density, membrane state, mitochondrial condition, redox balance, tissue geometry, developmental stage, and endogenous biological phase.

That is why RF Safe says the receiver is part of the biological dose.

Ambient Wi-Fi Is Not Biologically Empty

Wi-Fi is often dismissed because its average power is low.

But low average power does not mean zero biological information.

Wi-Fi is a time-structured microwave signal. Its transmissions contain bursts, duty cycles, packet timing, changing amplitudes, and multiple interacting devices. The biological question is not only how much energy is absorbed. It is whether the temporal structure of that energy interacts with a living system whose own control signals are encoded in timing, frequency, phase, and recovery.

A cell does not need to be burned in order to be perturbed.

A timing system can be disrupted by a timing error.

The experimental literature already shows RF-associated oxidative changes, calcium-related effects, mitochondrial responses, electrophysiological changes, and genotype-conditioned outcomes under defined conditions. The remaining work is to map the response surface accurately: which waveforms, which tissues, which developmental periods, which genotypes, which exposure histories, and which endogenous phases produce the largest loss of fidelity.

It is no longer scientifically responsible to treat continuous indoor RF exposure as irrelevant simply because it is non-ionizing and usually non-thermal.

The right question is not, “Can Wi-Fi cook the body?”

The right question is, “Can chronic, time-structured exposure lower the precision, recovery margin, or signal-to-noise ratio of a susceptible biological receiver?”

RF Safe’s position is that the evidence already justifies treating non-native RF as a fidelity stressor. The exact disease outcome is downstream, conditional, and receiver-dependent.

That is why the framework does not need Wi-Fi to map directly to autoimmune gastritis, cancer, infertility, autism, or metabolic syndrome.

It operates farther upstream.

Matter Pollution and Control Pollution

Bryan Johnson has placed major emphasis on reducing chemical contaminants, including microplastics.

That is important. Microplastics are matter pollution. They alter what is physically present in the body.

But living systems are also sensitive to the organization of energy in time.

A chemical contaminant can change molecular composition. A time-structured field can change when a membrane sensor moves, when an ion channel opens, when calcium enters, when mitochondria respond, and when a transcription factor reaches the nucleus.

This is control pollution.

The two categories can interact. Chemical toxicants can reduce antioxidant reserve or change membranes. Sleep loss can weaken repair. Circadian disruption can shift the phase reference. RF exposure can add another time-structured input to the same already-stressed system.

A complete longevity program must therefore measure more than nutrients, toxins, and static biomarkers. It must measure the fidelity ecology surrounding the body:

  • Light timing
  • Sleep timing
  • Air quality
  • Metabolic load
  • Inflammatory load
  • Chemical contaminants
  • Sound and vibration
  • Electromagnetic waveform exposure
  • Recovery after perturbation

A body can have perfect ingredients and still receive corrupted timing.

ROS, Biophotons, and Informational Oxidation

Reactive oxygen species are not simply waste. At controlled levels, they participate in signaling, immunity, adaptation, and repair. When production becomes excessive, mistimed, or poorly resolved, the same chemistry can damage proteins, lipids, nucleic acids, and membranes.

ROS-linked chemistry also produces electronically excited molecules that release ultra-weak photon emission, often called biophotons. The existence of this faint biological glow is established, and a 2026 Nature feature highlighted the growing scientific interest in using it as a marker of metabolism, stress, disease, and possibly cellular communication. [11]

The ceLLM hypothesis proposes that these emissions may be part of a photonic-redox audit trail. The important variable would not be brightness alone. It would be the relationship among source location, wavelength, burst timing, metabolic state, and the receiving cell’s geometry and phase.

A stressed cell may emit more photons while carrying less reliable biological information.

More photon load can coexist with lower photonic fidelity.

This helps define informational oxidation.

Informational oxidation is not a new chemical species. It is the gradual corrosion of the relationships that allow biology to interpret itself correctly:

Input. Timing. Execution. Readback. Recovery. Update.

When those relationships drift, the cell may compensate by changing channel expression, mitochondrial organization, chromatin state, inflammatory programs, and metabolic allocation. Those adaptations can preserve short-term survival while making the future system less robust.

The Embodied Cellular Transfer Function paper calls this fidelity debt and somatic overfitting. The cell becomes adapted to the distorted condition that stressed it, while losing the flexibility to operate cleanly in its native environment. [12]

That is how a temporary perturbation can become a persistent low-fidelity state.

Why This Is Transgenerational

Biological timing is especially important during gamete formation, fertilization, embryonic development, and early tissue patterning.

Development is not produced by genes acting as a simple list. It depends on membrane voltage, ion gradients, calcium timing, mitochondrial state, redox control, cell migration, chromatin accessibility, and communication among cells.

When the fidelity of those systems is altered during critical windows, the consequence can extend far beyond a temporary adult symptom. It can affect how an organism is built, how immune tolerance is established, how metabolic setpoints are calibrated, and how future tissues respond to stress.

That is why low-fidelity biology is not only a personal wellness issue. It is a transgenerational public-health concern.

The goal is not to blame one exposure for every outcome. The goal is to protect the fidelity of the biological processes through which one generation becomes the next.

The Experiment Bryan Johnson’S Team Should Run

Bryan Johnson is uniquely positioned to test this framework because he already has longitudinal data, standardized routines, advanced single-cell analysis, sleep monitoring, organoid work, and the resources to conduct properly blinded experiments.

His team should add a Bioelectric Fidelity Program.

1. Map the full electromagnetic exposome

Measure RF exposure during sleep, work, exercise, travel, device use, and wearable use. Preserve time-resolved waveform information rather than reporting only a broadband average.

2. Sequence the immune cells, then measure their dynamics

Single-cell and T-cell receptor sequencing can identify the clonotypes participating in the gastric attack. The same cells should be tested for membrane voltage, Kv1.3 activity, STIM1-ORAI1 calcium entry, mitochondrial membrane potential, ROS dynamics, NFAT and NF-kB activation, cytokine production, and recovery after stimulation.

3. Build a personalized gastric organoid and immune-cell model

Combine Johnson’s gastric organoids with his own immune-cell populations. Expose the system to gastric proton-pump antigens under tightly controlled conditions and observe when tolerance holds and when self-attack begins.

4. Use blinded waveform comparisons

Compare sham exposure, a measured real-world waveform, a continuous-wave condition, and a time-scrambled condition with matched energy and temperature. The decisive question is whether the original temporal structure produces a biological effect that energy-matched scrambling does not.

5. Measure Fidelity Age

A useful fidelity score should include target discrimination, timing stability, off-target activation, mitochondrial cost, recovery time, hysteresis, and persistence after the challenge ends.

This would move longevity science beyond resting dashboards.

It would measure the controller.

Why This Question Is Personal to Me

I lost my left kidney to cancer as a child.

Years later, my first child died from anencephaly, a catastrophic failure of early developmental patterning.

Those experiences forced me to look upstream of disease labels.

Cancer is a failure of growth control, tissue identity, and coordinated restraint. Anencephaly is a failure of developmental closure and pattern formation. Autoimmunity is a failure of self-recognition and tolerance.

These are different outcomes. The common question is deeper:

How does living biology lose the ability to interpret timing, position, identity, and environmental context correctly?

That question led to RF Safe and to the concept of low-fidelity biology.

The central concern is not that radiofrequency exposure must map directly to one named disease. The concern is that chronic environmental timing noise can reduce the margin of precision in the bioelectric and redox systems that keep many disease states inaccessible.

When the upstream operating environment becomes noisier, the downstream failures will differ according to genetics, tissue architecture, age, developmental timing, prior injury, and metabolic reserve.

That is exactly what a meta-disease framework predicts.

The Next Revolution in Longevity Is Fidelity Preservation

Bryan Johnson’s autoimmune gastritis does not show that optimizing the body is pointless.

It shows that optimization is incomplete when it measures ingredients and outputs but not the quality of biological control.

You can normalize iron without correcting why the stomach stopped absorbing it.

You can improve strength, glucose, lipids, and cardiovascular performance without correcting an immune system that continues to classify self as danger.

You can make the parts look younger while an old control error remains embedded in the network.

You can rebuild the engine and still lose the timing.

The next generation of longevity science must measure:

  • State Age
  • Performance Age
  • Fidelity Age

The deepest goal is not simply to make every biomarker look young.

It is to preserve the high-fidelity coordination that allows the body to distinguish self from non-self, danger from noise, repair from overreaction, and adaptation from self-destruction.

Bryan, you have optimized the chemistry.

Now measure the timing.

The future of longevity may depend on it.

Read the Full ceLLM Hypothesis Paper

The Embodied Cellular Transfer Function: Noncoding Response Architecture, Bioelectric State Inference, and Geometry-Addressed Photonic Reafference in Living Systems

Read the full paper: The Embodied Cellular Transfer Function

References

  1. Bryan Johnson. Official X post announcing autoimmune gastritis and chronic low ferritin. July 2026.
  2. Lenti MV, et al. Autoimmune gastritis. Nature Reviews Disease Primers / review literature. PMID: 32647173.
  3. O’Donoghue GP, et al. T cells selectively filter oscillatory signals on the minutes timescale. PNAS. 2021;118:e2019285118.
  4. Rangaraju S, et al. Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opinion on Therapeutic Targets. 2009;13:909-924.
  5. Lioudyno MI, et al. Orai1 and STIM1 move to the immunological synapse and are up-regulated during T cell activation. PNAS. 2008;105:2011-2016.
  6. Yakymenko I, et al. Oxidative mechanisms of biological activity of low-intensity radiofrequency radiation. Electromagnetic Biology and Medicine. 2016;35:186-202.
  7. Meyer F, et al. The effects of radiofrequency electromagnetic field exposure on biomarkers of oxidative stress in vivo and in vitro: a systematic review of experimental studies. Environment International. 2024;194:108940.
  8. Kim J, et al. Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression. Cell. 2026;189:3465-3480.e23. doi: 10.1016/j.cell.2026.03.029.
  9. Sousouri G, et al. 5G radio-frequency-electromagnetic-field effects on the human sleep electroencephalogram: a randomized controlled study in CACNA1C genotyped volunteers. NeuroImage. 2025;317:121340.
  10. U.S. Food and Drug Administration. TheraBionic P1, H220001. Approved September 26, 2023.
  11. Marchant J. All living things emit a faint glow. Could this light be useful? Nature. July 28, 2026.
  12. Coates J. The Embodied Cellular Transfer Function. RF Safe. Version 1.0, July 2026.